Induction of drug-metabolizing enzymes: A path to the discovery of multiple cytochromes P450

被引:67
作者
Conney, AH [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA
关键词
environmental regulation of xenobiotic metabolism; microsomal enzyme induction; activation of microsomal enzymes; drug-drug interactions; diet-drug interactions;
D O I
10.1146/annurev.pharmtox.43.100901.135754
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article provides a personal account of the discovery of the induced synthesis of drug-metabolizing enzymes and of subsequent research that led to the discovery of multiple cytochromes P450 with different catalytic activities. The manuscript also emphasizes the role of environmental factors (in addition to genetic polymorphisms) in explaining person-to-person and day-to-day differences in rates and pathways of drug metabolism that occur in the human population.
引用
收藏
页码:1 / 30
页数:30
相关论文
共 50 条
  • [41] In vitro study on the effect of ophiopogonin D on the activity of cytochrome P450 enzymes
    Ji, Xiaofei
    Ding, Baodong
    Wu, Xiaoyou
    Liu, Fengyi
    Yang, Fengqi
    XENOBIOTICA, 2021, 51 (03) : 262 - 267
  • [42] Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine's Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes
    Yin, Xuefen
    Cicali, Brian
    Rodriguez-Vera, Leyanis
    Lukacova, Viera
    Cristofoletti, Rodrigo
    Schmidt, Stephan
    PHARMACEUTICS, 2024, 16 (06)
  • [43] Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction
    Li, AP
    Maurel, P
    GomezLechon, MJ
    Cheng, LC
    JurimaRomet, M
    CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 107 (1-2) : 5 - 16
  • [44] Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction
    Kumar, Gondi
    Lau, Henry
    Laskin, Oscar
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1171 - 1175
  • [45] Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review
    Smith, Sarah Ann
    Le, Gia Han
    Teopiz, Kayla M.
    Kwan, Angela T. H.
    Rhee, Taeho Greg
    Ho, Roger C.
    Wu, Jie
    Cao, Bing
    Ceban, Felicia
    McIntyre, Roger S.
    DRUG METABOLISM REVIEWS, 2024, 56 (02) : 164 - 174
  • [46] Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro
    Han, Yong-Long
    Yu, Hong-Liang
    Li, Dan
    Meng, Xiang-Le
    Zhou, Zhi-Yong
    Yu, Qi
    Zhang, Xiao-You
    Wang, Fu-Jing
    Guo, Cheng
    TOXICOLOGY IN VITRO, 2011, 25 (08) : 1828 - 1833
  • [47] Statistical Methods for Analysis of Time-Dependent Inhibition of Cytochrome P450 Enzymes
    Yates, Phillip
    Eng, Heather
    Di, Li
    Obach, R. Scott
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (12) : 2289 - 2296
  • [48] Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice
    He, Wei
    Wu, Jing-Jing
    Ning, Jing
    Hou, Jie
    Xin, Hong
    He, Yu-Qi
    Ge, Guang-Bo
    Xu, Wei
    TOXICOLOGY IN VITRO, 2015, 29 (07) : 1569 - 1576
  • [49] Molecular probes for human cytochrome P450 enzymes: Recent progress and future perspectives
    Wu, Jingjing
    Guan, Xiaoqing
    Dai, Ziru
    He, Rongjing
    Ding, Xinxin
    Yang, Ling
    Ge, Guangbo
    COORDINATION CHEMISTRY REVIEWS, 2021, 427
  • [50] Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications
    Guengerich, F. Peter
    BIOMOLECULES & THERAPEUTICS, 2022, 30 (01) : 1 - 18